Some Pancreatic Cancer Families Hit Insurance Delays After Rasonque Approval Closed the Drug's Free Early Access Program
FDA approval of the pancreatic cancer pill Rasonque closed its free early access program before some insurers were ready to cover it.
Medical Daily ·